MAR 28, 2020 7:21 AM PDT

FDA Approves 5-Minute Coronavirus Test

WRITTEN BY: Annie Lennon

In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change thanks to the FDA’s approval of a rapid-testing device by Abbott Laboratories capable of telling if someone is infected with the virus in just five minutes. 

John Frels, vice president of research and development at Abbott Diagnostics, said, “This is really going to provide a tremendous opportunity for front-line caregivers, those having to diagnose a lot of infections, to close the gap with our testing...A clinic will be able to turn that result around quickly, while the patient is waiting.”

To take the test, medical practitioners must take a swab from a patient’s nose or the back of their throat. Then mixing the swab in a chemical solution to break the virus down and release its RNA for identification, it is then inserted into an ID Now system, a box weighing less than 7 pounds. This box then identifies and reads select sequences relevant to the coronavirus genome. Taking just five minutes to deliver positive results when the patient has a high viral load, a more thorough analysis to rule out the virus altogether takes up to 13 minutes. 

Abbott Diagnostics has said that they will be able to make 50,000 of these tests per day from April 1st, and that they can be used in practically any healthcare setting. Thus, the US government initially plans on delivering them to where they are most needed- particularly in hospital emergency rooms, urgent-care clinics and doctors’ offices. 

This news comes after the FDA’s approval of Abbott’s m2000 RealTime system, another diagnostic technique that, although takes longer to produce results, can be produced at a much faster rate: up to 1 million tests per week. The two systems taken together mean that Abbott will soon be able to create at least 5 million tests per month. 

Meanwhile, other companies have also been working hard to deliver diagnostic tools for the coronavirus. Henry Schein Inc, for example, announced the availability of its point-of care antibody test. Looking for evidence that a person’s immune system has already fought off the virus, the blood test delivers results within 15 minutes, although it can’t be used to detect current infections. 


Sources: Bloomberg, Chicago Business and CNN 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 11, 2022
Cell & Molecular Biology
From sample collection straight to RT-qPCR
AUG 11, 2022
From sample collection straight to RT-qPCR
Skip the nucleic acid purification step in your cancer detection workflow. Learn more about how Thermo Fisher Scientific ...
JUN 08, 2022
Coronavirus
How are you Preparing for the Next Covid Surge?
JUN 08, 2022
How are you Preparing for the Next Covid Surge?
After two years of uncertainty, we can definitely say that the coronavirus (Covid-19) has changed our everyday lives as ...
JUN 20, 2022
Health & Medicine
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
JUN 20, 2022
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
The New England Journal of Medicine published results from a small study by researchers at New York’s Memorial Slo ...
JUL 12, 2022
Drug Discovery & Development
Nitric Oxide Reduces Hospital Stay of Pregnant Women with COVID-19
JUL 12, 2022
Nitric Oxide Reduces Hospital Stay of Pregnant Women with COVID-19
High-dose nitric oxide can reduce the length of hospital and ICU stay, as well as the need for supplemental oxygen, amon ...
JUL 15, 2022
Cannabis Sciences
Cannabis Legalization's Impact on Foster Care Placements
JUL 15, 2022
Cannabis Legalization's Impact on Foster Care Placements
A study published in the journal Economic Inquiry analyzed the potential impacts of federal cannabis legalization on fos ...
AUG 12, 2022
Technology
Bioengineered Cornea Helps Restore Sight for the Visually Impaired
AUG 12, 2022
Bioengineered Cornea Helps Restore Sight for the Visually Impaired
Corneal disease refers to a range of conditions that can cause significant damage to the cornea, the clear tissue layer ...
Loading Comments...